Epodure: Interim Phase IIa data

Interim data from 4 ESRD patients with anemia who are on dialysis in an open-label, Israeli Phase IIa trial showed that a single treatment of 19-51 IU/kg/day subcutaneous Epodure maintained hemoglobin...